INTENSITY THERAPEUTICS, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Intensity Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2022 to Q3 2024.
  • Intensity Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $483K, a 37.6% increase year-over-year.
  • Intensity Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $2.65M.
  • Intensity Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.4M, a 19.6% increase from 2022.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $2.65M $483K +$132K +37.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $2.52M $591K +$279K +89.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $2.24M $1.16M +$843K +270% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $1.4M $423K Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 $351K +$314K +849% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $312K +$116K +59.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $312K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q3 2022 $37K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $196K Apr 1, 2022 Jun 30, 2022 10-Q/A 2023-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.